EpiHeart

Cardiac Micrograft Therapy™ — a micrograft made during surgery from the patient's own heart tissue (atrial appendage) to treat ischaemic heart failure. Univ. of Helsinki/HUS spin-out; first clinical uses done (e.g. alongside LVAD surgery).

The row

Sector

Medtech & Digital Health

Stage

Pre-revenue — No sales yet

Location

Helsinki

Founded

2019

Research origin

Univ. of Helsinki

Business ID

3107385-1 · Finnish trade register

Funding

€0.6M (2021) + further funding in 2024

Links

Where this sits on the map

EpiHeart is one of 33 companies in Medtech & Digital Health. The others:

How this row was decided

Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗